Opportunity ID: 282325

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-16-012
Funding Opportunity Title: Investigation of Peptide-Polymer Interaction in Poly(lactide-co-glycolide) Microspheres (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration_Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 17, 2016
Last Updated Date:
Original Closing Date for Applications: May 20, 2016
Current Closing Date for Applications: May 20, 2016
Archive Date: Jun 19, 2016
Estimated Total Program Funding: $250,000
Award Ceiling: $250,000
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
City or township governments
Independent school districts
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Small businesses
For profit organizations other than small businesses
Public and State controlled institutions of higher education
State governments
County governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organization are not eligible to apply.
Foreign components, are not allowed.

Additional Information

Agency Name: Food and Drug Administration
Description: Although biodegradable poly(lactide-co-glycolide) (PLGA) polymers have been utilized extensively for the controlled release of peptide drugs, there is still a lack of in-depth understanding of peptide-polymer interaction in PLGA based microspheres. The purpose of the present study is to develop a systematic approach to assess the peptide-polymer interaction in PLGA based microsphere dosage forms. The developed approach should be able to identify the different types of peptide-polymer interactions, characterize and quantify related peptide degradation impurities (e.g., acylation peptide adducts), and determine the formulation parameters, hydration and degradation factors, and manufacturing processes responsible for facilitating peptide-polymer interaction. The results from this study will provide better understanding of peptide-polymer interaction in PLGA based drug delivery systems, which will help the Agency in developing recommendations for evaluation of generic microspheres containing peptide drugs.
Link to Additional Information: Full Announcement of RFA-FD-16-012
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Eric Bozoian

Grants Management Specialist

Phone 2404027623
Email:eric.bozoian@fda.hhs.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: Eric Bozoian
Grants Management Specialist
Phone 2404027623
Email: eric.bozoian@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 PKG00221681 Mar 21, 2016 May 20, 2016 View

Package 1

Mandatory forms

282325 RR_SF424_2_0-2.0.pdf

282325 PHS398_CoverPageSupplement_3_0-3.0.pdf

282325 RR_OtherProjectInfo_1_3-1.3.pdf

282325 PerformanceSite_2_0-2.0.pdf

282325 RR_KeyPersonExpanded_2_0-2.0.pdf

282325 RR_Budget_1_3-1.3.pdf

282325 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282325 RR_SubawardBudget30_1_3-1.3.pdf

282325 PHS_Inclusion_Enrollment_Report-1.0.pdf

282325 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T10:54:05-05:00

Share This Post, Choose Your Platform!

About the Author: